Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 901–1,000 of 1,000
Abou-Kheir, W. G., Mukherji, D., Hadadeh, O., Saleh, E., Bahmad, H. F., Kanso, M., Khalifeh, M., Shamseddine, A. I., Tamraz, S., Jaafar, R. F., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03842 · Cited by 3
Modern Approaches to Testing Drug Sensitivity of Patients’ Tumors (Review)
Николаевна, Д. И., Shirmanova, M. V., Kuznetsova, D. S., Lukina, M. M., & Вадимовна, З. Е. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.4.11 · Cited by 3
Neuroblastoma: Current advancements and future therapeutics
Ng, S. W., Chan, Y., Ng, X. Y., Dua, K., & Chellappan, D. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00001-8 · Cited by 6
Inhibitory effect of Sargassum latifolium extract on hypoxia pathway in colon cancer cells
Gamal‐Eldeen, A. M., Raafat, B. M., El‐Daly, S. M., Fahmy, C. A., Almehmadi, M. M., & Althobaiti, F. (2021) · Emirates Journal of Food and Agriculture · doi:10.9755/ejfa.2021.v33.i7.2727 · Cited by 3
Molecular and therapeutic bases of cancer
Fajardo-Orduña, G. R., & Chamorro-Plata, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819828-5.00002-4 · Cited by 3
Laboratory biomarkers of an effective antitumor immune response. Clinical significance.
Malkova, A. M., Sharoyko, V. V., Zhukova, N. V., Gubal, A. R., & Орлова, Р. В. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100489 · Cited by 5
Risk score model of autophagy-related genes in osteosarcoma
Jiang, M., Fang, D., He, X., Huang, J., Hu, Y., Xie, M., Jike, Y., Bo, Z., & Qin, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-166 · Cited by 3
A dual role of proton pump inhibition on cancer: a critical review
Edızer, D. T., Akcali, Z., Leblebici, A., Korkut, S. Ö., & Ellidokuz, E. (2023) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2021-0296 · Cited by 3
Jin, Q., Mei, J., Lin, H., Wang, R., Wu, S.-Y., Wang, S., Jiang, X., Yang, Y., Yao, H., Zhang, W., et al. (2023) · Medicina · doi:10.3390/medicina59020358 · Cited by 4
Establishment of FAP-overexpressing Cells for FAP-targeted Theranostics
Jian, H.-R., Niu, W.-H., Xu, Z., Zhu, J.-X., Pan, X., Zhang, Y.-R., Lei, P., Huang, F.-Q., & He, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2740-7 · Cited by 4
Moeinzadeh, L., Ramezani, A., Mehdipour, F., Yazdanpanah‐Samani, M., & Razmkhah, M. (2023) · BioMed Research International · doi:10.1155/2023/7692726 · Cited by 3
Ferré, A. E., Komaty, S., Hélaine, C., Anfray, C., Ghojavand, S., Coupey, J., Saulnier, R., Bernay, B., Chazalviel, L., Mintova, S., et al. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113524 · Cited by 3
Zaalberg, A., Pottendorfer, E., Zwart, W. T., & Bergman, A. M. (2024) · Cancers · doi:10.3390/cancers16020294 · Cited by 6
Chen, M., Yan, X., Hong, B., Xiao, Y., & Qian, Y. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.93262 · Cited by 3
Cancer Progression Related with Tumor-associated Macrophages
Ethiraj, P., Loganathan, T., & Arul, S. (2016) · Cancer and Oncology Research · doi:10.13189/cor.2016.040401 · Cited by 3
Guo, Y. S., Hu, J., Zhao, Z., Zhong, G., Gong, J., & Cai, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719355 · Cited by 4
Nan, X., Liu, Y., Gao, Y., & Nan, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1155199 · Cited by 3
Wang, C., Wei, J., & Fang, D. (2021) · Research Square · doi:10.21203/rs.3.rs-422168/v1 · Cited by 3
Zhou, B. O., Sun, M., Yang, M., Cui, W., & Yang, H. (2025) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-2025-504 · Cited by 3
Shang, Z., Wang, Z., Zhang, Y., & Liu, S. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-747 · Cited by 2
Fang, X., Zheng, S., Fang, Z., Wu, X., Schenk, E. L., Belluomini, L., & Fan, H. (2025) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-297 · Cited by 2
Deciphering hypoxia’s role in hepatocellular carcinoma prognosis with single-cell approaches
Liang, J., Chen, D., & Liang, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03201-y · Cited by 5
Feng, Q., Zheng, D., Ma, Z., Liang, J., Liu, S., Yao, G., Li, J., & Wang, Z. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.138945 · Cited by 2
Shi, Y., Bai, Y., Wu, J., Yu, Y., Yang, X., Yang, H., Jian, W., & Qing, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1693028 · Cited by 2
Brain tumors: diagnosis and treatment
Dubey, A. K., Shen, B., & Singla, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33910-3.00012-1 · Cited by 2
Controlled intra- and extracellular localization of bioorthogonal polymeric nanozymes
Hirschbiegel, C., Shrikanth, M., Çiçek, Y. A., Nasim, N., Truong, J., Yang, J., Ribbe, A. E., Abdelaziz, M., & Rotello, V. M. (2026) · Chemical Science · doi:10.1039/d5sc07223a · Cited by 2
Martell-Huguet, E. M., Morán‐Ávila, T., Villuendas, J. E., Rodriguez, A., Kissmann, A., Ständker, L., Wiese, S., Otero‐González, A. J., & Rosenau, F. (2026) · Marine Drugs · doi:10.3390/md24010032 · Cited by 2
Zhang, L., Han, X., Gao, X., Chen, H., Shang, C., Chen, L., Lin, J., & Guo, H. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106225 · Cited by 2
Gao, X., Wang, W., Sun, M., Zhao, H., Shang, Z., Wong, A. S. T., Wang, Y., Zhao, M., & Liu, D. (2026) · Biomedical Technology · doi:10.1016/j.bmt.2026.100138 · Cited by 3
Ding, D., Huang, Z., Wang, L., Wang, Z., Qin, J., Ni, M., Yao, B., & Yang, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04334-0 · Cited by 2
Inhibition of GPR68 induces ferroptosis in diffuse intrinsic pontine gliomas
Neitzel, L. R., Wasserman, A. H., Hashizume, R., Williams, C. H., & Hong, C. C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1808752 · Cited by 2
Xia, L., Yuan, C., Duan, Y., Huang, W., Yang, Z., Wang, M., Xu, M., Chen, Z., Chen, Y., Li, X., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124462 · Cited by 2
Chang, F., Zhang, J., Wu, W.-S., Tang, S., Lv, Z., & Chen, F. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05215-1 · Cited by 2
IL-7R Expression Correlates with Prognosis in Breast Cancer
Yu, X., Zhang, H., Liu, J., Hou, C., Zhang, H., & Yang, Z. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073293963240409040110 · Cited by 2
Saini, V., Do, Y., Yam, J. W. P., & Wong, Y. H. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111203 · Cited by 2
Quenneville, J., Feghaly, A., Tual, M., Thomas, K., Major, F., & Gagnon, É. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00795-3 · Cited by 2
Chen, S., Karekad, M. M. A., Liu, T., Ding, B., Wang, R., Sun, Q., Xu, X., & Shi, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1531493 · Cited by 2
Zhang, J., Fang, R., Song, N., Jin, Y., Zhang, M., Wang, J., Peng, Q., Ren, H., Zhang, Y., & Yang, X. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02216 · Cited by 2
Fei, L., Lu, Z., Xu, Y., & Hou, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920897 · Cited by 2
Immunohistochemical study of uveal melanoma and its cellular microenvironment
Saakyan, S. V., Катаргина, Л. А., Myakoshina, E. B., Захарова, Г. П., Хорошилова-Маслова, И. П., & Майбогин, А. М. (2022) · Advances in molecular oncology · doi:10.17650/2313-805x-2022-9-2-97-104 · Cited by 2
A hypoxia risk score for prognosis prediction and tumor microenvironment in adrenocortical carcinoma
Deng, Y., Li, H., Fu, J., Pu, Y. D., Zhang, Y., Chen, S., Tong, S., & Liu, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.796681 · Cited by 2
Smart systems in bio-encapsulation for cancer therapy
Ferreira, N. N., Cancino‐Bernardi, J., Cardoso, V. M. D. O., Comparetti, E. J., Miranda, R. R., Ferreira, L. M. B., & Zucolotto, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00015-5 · Cited by 2
Jumat, N. R., Yunus, M. A., Yahaya, B. H., & Mohamed, R. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i12.781 · Cited by 3
Yin, Z., Zhao, Y., Zhou, W., You, C., Bai, Y., You, B., Lu, D., Liao, S., Zheng, L., Sun, Y., et al. (2023) · Journal of Oncology · doi:10.1155/2023/1302278 · Cited by 2
Engineered Tissue in Cancer Research: Techniques, Challenges, and Current Status
Tripathi, D., Shukla, V., Sahoo, J., Sharma, D. K., & Shukla, T. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_8 · Cited by 3
Chen, W., Wang, Y., Gu, H., Zhang, Y., Chen, C., Yu, T., & Chen, T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1109181 · Cited by 2
Yuan, D., Zheng, B., Zheng, B., Niu, H.-Q., Zou, M., Liu, S., & Liu, F. (2023) · European journal of medical research · doi:10.1186/s40001-023-01527-3 · Cited by 2
Liu, H., Ma, X., Pan, D., Cao, M., Han, Z., & Wang, H. (2023) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/2023/2859670 · Cited by 2
Demir, Ö., Demirağ, G., Çakmak, F., Bayraktar, D. I., & Tokmak, L. (2024) · BMC Neurology · doi:10.1186/s12883-024-03639-7 · Cited by 2
Reigosa, F., Cordeiro, S. Z., Pereira, M. T., Filipe, B., Baptista, P. V., Fernandes, A. R., & Vila, J. M. (2024) · Dalton Transactions · doi:10.1039/d4dt01490a · Cited by 2
Self-citationHe, Q., Su, Q., Wei, C., Zhang, P., Liu, W., Chen, J., Su, X., & Zhuang, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464145 · Cited by 2
Yang, H. (2024) · Cytology and Genetics · doi:10.3103/s0095452724050141 · Cited by 2
Bioinformatics analysis and experimental validation of the oncogenic role of COL11A1 in pan-cancer
Wan, X., Deng, Q., Chen, A., Zhang, X., & Yang, W. (2024) · 3 Biotech · doi:10.1007/s13205-024-04133-0 · Cited by 2
5-Hydroxymethylcytosine profilings in circulating cell-free DNA as diagnostic biomarkers for DLBCL
Duolikun, M., Ding, Y., Zhang, L., Li, X., Xiao, H., Kuerban, S., Zhen, B., Wang, Y., Chen, L., Chen, H., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1387959 · Cited by 4
Qu, J., Wang, M., Gao, Y.-H., & Zhang, H. (2025) · Cancer Informatics · doi:10.1177/11769351251316398 · Cited by 3
Redox-responsive vesicular carriers for potential tumor-targeting applications
Rathee, S., Sahu, A., Patil, U. K., & Jain, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29125-8.00006-5 · Cited by 2
Zhu, Y., Zhang, J., Zhao, X., Guo, M., Chen, C., Zhou, Y., & Xu, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107822 · Cited by 3
VAMP proteins: molecular architects in disease pathogenesis and therapeutic innovation
Yu, D., Zhang, H., Ding, X., Guo, J., & Yang, L. (2025) · Medical Oncology · doi:10.1007/s12032-025-02969-x · Cited by 2
Fu, Y., & Sun, H. (2022) · BioMed Research International · doi:10.1155/2022/7356992 · Cited by 2
Potential targeting sites in brain and brain tumors
Kaur, A., Sharma, S., Noor, A., Dang, S., & Talegaonkar, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00017-8 · Cited by 2
Tang, X., Miao, Y., Yang, L., Ha, W., Li, Z., & Mi, D. (2023) · IET Systems Biology · doi:10.1049/syb2.12072 · Cited by 2
Stephenson-Gussinye, A., Rendón-Bautista, L. A., Ruiz-Medina, B. E., Olais, E. B., Pérez‐Molina, R., Marcial-Medina, C., Chávarri-Guerra, Y., Soto‐Pérez‐de‐Celis, E., Morales-Alfaro, A., Esquivel-López, A., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1420308 · Cited by 2
Single-Cell Multiomics: Dissecting Cancer
Sambath, J., Patel, K., Limaye, S. A., & Kumar, P. (2020) · Algorithms for intelligent systems · doi:10.1007/978-981-15-2445-5_14 · Cited by 2
The Role of Inflammatory Cells in Tumor Angiogenesis
Tamma, R., Annese, T., & Ribatti, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_14 · Cited by 2
Clinical Significance of COL11A1 and Its Effect on Immune Infiltration in Colorectal CancerPreprint
Wu, Y., Cai, Y., Chen, W., Tao, Y., Xu, Y., & Wang, H. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3514645 · Cited by 2
Fan, Y., Hao, J., Cen, X., Song, K., Yang, C., Xiao, S., & Cheng, S. (2024) · Research Square · doi:10.21203/rs.3.rs-5511003/v1 · Cited by 2
Evaluation The Role of CD33+ CD11b+ myeloid-derived Suppressor Cells in Patients With AML
Hamad, H., Shabeeb, Z., & Awad, M. M. (2022) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2022.174817 · Cited by 1
Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis
Khade, O., Nagrekar, S., Parab, V., & Choubey, A. (2023) · Diseases & Research · doi:10.54457/dr.202301007 · Cited by 1
Research Progress in the Regulation of Tumor Microenvironment for Vascular Normalization
李, 璐. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.134883 · Cited by 1
Zhang, X., Qiu, S., & Wang, C. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230503094337 · Cited by 1
Combination Therapies for the Management of Cancer Immunotherapy
Chenchula, S., Anitha, K., Posinasetty, B., Bhatt, S., Mishra, N., Sharma, N., & Chandran, P. (2024) · Springer eBooks · doi:10.1007/978-981-97-7022-9_5 · Cited by 1
Huang, S., Zhang, T., Shi, C., Ye, Z., Xu, J., Su, J., Wei, D., Wang, X., & Zhong, J. Q. (2025) · Springer eBooks · doi:10.1007/978-981-19-8930-8_9 · Cited by 1
Mavaei, M., Farokhi, S., Yousefi, M. H., Fakouri, A., Shadab, A., Abdolmohammadi, M. H., Fallahian, F., & Afkhami, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1533065 · Cited by 1
Li, S., Cheng, X., Zuo, E., & Lian, L. (2025) · Journal of computational genomics and biology · doi:10.59995/j2bdqx49 · Cited by 1
Lasagna, A. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2516995 · Cited by 1
Su, R., Chen, J., Dai, C., Yin, S., Chen, H., Sun, X., Fang, Z., Zhang, C., Chen, J., & Gu, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-01472-7 · Cited by 1
Wang, X., Zhu, J., Liu, C., Zhang, H., Sun, G., Zhai, J., Yang, H.-J., & Liu, D.-C. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i25.107478 · Cited by 1
Li, Y., Su, P., & Sun, X. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13658 · Cited by 1
Rafik, S. T., Upadhyay, A., MacRobert, A. J., & Cheema, U. (2026) · The FASEB Journal · doi:10.1096/fj.202503695r · Cited by 1
Bondì, G., Martella, S., Stylianakis, D., Terminella, A., Lococo, F., Ciarrocchi, A., Fiorelli, A., & Cusumano, G. (2026) · Current Oncology · doi:10.3390/curroncol33020093 · Cited by 2
The Chemistry of Deception: Exploiting Tumor Hypoxia With Cobalt Prodrugs
Ghosh, D., Bhar, S., Das, T., Kar, K., Afreen, R., Das, D., & Chandra, A. (2026) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202500540 · Cited by 2
Lei, L., Yang, H., Du, M., & Chen, Y. (2026) · BIO Integration · doi:10.15212/bioi-2025-0117 · Cited by 2
Recent Applications of Tissue-Engineered 3D Scaffolds in Oncology: Present and Future Perspectives
Tripathi, D., Gupta, V. K., & Pandey, P. K. (2026) · Protein and Peptide Letters · doi:10.2174/0109298665391686251124053211 · Cited by 1
Shi, S., Liu, H., 彭清平, Nan, S., Liu, S., Wei, L., Wang, H., Wang, K., Zhong, X., Chen, X., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c01369 · Cited by 1
Bibliometric analysis of single-cell RNA sequencing in tumor microenvironment
Ma, J., Chen, T., Shen, K., Fang, M., Zhang, Y., Yang, L., & Guo, L. (2026) · Discover Oncology · doi:10.1007/s12672-026-05073-2 · Cited by 1
Saravanan, V., Angeli, A., Melfi, F., Amodio, N., Valentino, I., Gentile, M., D’Agostino, I., Muthukumaradoss, K., Zengin, G., Moi, D., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19050717 · Cited by 1
Yang, H., Zhou, C., Zhou, Z., Zhang, F., & Tong, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116911 · Cited by 1
Wu, J., Lai, T. P., Li, L., Yuan, Y., Wang, Y., Liu, G., Li, W., Zhang, L., & Wan, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115137 · Cited by 1
Tjingson, N., Rizal, M. I., & Sandra, F. (2026) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v10i2.784 · Cited by 2
Targeting the tumor microenvironment and mitochondrial dynamics: A theranostic frontier in cancer
Kumar, U., Tyagi, L., & Ghosh, K. (2026) · Tumor Discovery · doi:10.36922/td026010002 · Cited by 1
Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects
Meftahpour, V., Dakal, T. C., Maciaczyk, J., Sharma, A., & Schmidt‐Wolf, I. G. H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02881-4 · Cited by 4
Rana, H., Patel, K., Dholakia, M. S., Thakkar, V. T., & Gandhi, T. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100796 · Cited by 1
Maroń, A. M., Cordeiro, S., Marques, C., Sequeira, R., Salas, B., Luz, A., Choroba, K., Zowiślok, B., Kula, S., Machura, B., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01362 · Cited by 1
Self-citationAdvanced nanoformulations for theranostics: current status and challenges
Basu, A., Hasnain, M. S., Nayak, A. K., & Aminabhavi, T. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85785-7.00035-8 · Cited by 1
Microfluidics and Cancer Treatment: Emerging Concept of Biomedical Engineering
Tawade, P. V., & Tondapurkar, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_15 · Cited by 2
Lin, A., Mou, W., Zhu, L., Yang, T., Zhou, C., Zhang, J., & Luo, P. (2023) · Cancer Innovation · doi:10.1002/cai2.84 · Cited by 1
Scott, H. C., Draganov, S. D., Yu, Z., Kessler, B. M., & Pinto-Fernández, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115513 · Cited by 1
High expression of ARPC1B correlates with immune infiltration and poor outcomes in glioblastoma
Liao, C., Chen, W. K., Xu, G., Wang, J., & Dong, W. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101619 · Cited by 3
Oxygen Delivery Microcapsules provide a Novel Strategy for the Treatment of Cancer
Sheng, J. (2021) · Current Trends in Biomedical Engineering & Biosciences · doi:10.19080/ctbeb.2021.20.556029 · Cited by 1
Styryl carbamate backbones for the discovery of TME-disrupting agents
Bou-Puerto, A., Cardá, M., & Falomir, E. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101372 · Cited by 1
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.